Literature DB >> 34252278

CSE-Derived H2S Inhibits Reactive Astrocytes Proliferation and Promotes Neural Functional Recovery after Cerebral Ischemia/Reperfusion Injury in Mice Via Inhibition of RhoA/ROCK2 Pathway.

Yang Zhang1, Kexin Li1, Xiangyi Wang1, Yanyu Ding1, Zhiruo Ren1, Jinglong Fang1, Tao Sun2, Yan Guo1, Zhiwu Chen1, Jiyue Wen1.   

Abstract

The effect of cystathionine-γ-lyase (CSE)-derived hydrogen sulfide (H2S) on the reactive proliferation of astrocytes and neural functional recovery over 30 d after acute cerebral ischemia and reperfusion (I/R) was determined by applying wild-type (WT) and CSE knockout (KO) mice. The changes of glial fibrillary acidic protein (GFAP) expression in hippocampal tissues was tested. Besides, we assessed the changes of mice spatial learning memory ability, neuronal damage, RhoA, Rho kinase 2 (ROCK2), and myelin basic protein (MBP) expressions in hippocampal tissues. The results revealed that cerebral I/R resulted in obvious increase of GFAP expression in hippocampal tissues. Besides, we found the neuronal damage, learning, and memory deficits of mice induced by cerebral I/R as well as revealed the upregulation of RhoA and ROCK2 expressions and reduced MBP expression in hipppcampal tissues of mice following cerebral I/R. Not surprisingly, the GFAP expression and cerebral injury as well as the upregulation of the RhoA/ROCK2 pathway were more remarkable in CSE KO mice, compared with those in WT mice over 30 d following acute cerebral I/R, which could be blocked by NaHS treatment, a donor of exogenous H2S. In addition, the ROCK inhibitor Fasudil also inhibited the reactive proliferation of astrocytes and ameliorated the recovery of neuronal function over 30 d after cerebral I/R. For the purpose of further confirmation of the role of H2S on the astrocytes proliferation following cerebral I/R, the immunofluorescence double staining: bromodeoxyuridine (BrdU) and GFAP was evaluated. There was a marked upregulation of BrdU-labeled cells coexpressed with GFAP in hippocampal tissues at 30 d after acute cerebral I/R; however, the increment of astrocytes proliferation could be ameliorated by both NaHS and Fasudil. These findings indicated that CSE-derived H2S could inhibit the reactive proliferation of astrocytes and promote the recovery of mice neural functional deficits induced by a cerebral I/R injury via inhibition of the RhoA/ROCK2 signal pathway.

Entities:  

Keywords:  H2S; RhoA/ROCK2 pathway; astrocytes; cerebral I/R; ischemia/reperfusion; neuronal function deficits

Year:  2021        PMID: 34252278     DOI: 10.1021/acschemneuro.0c00674

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  4 in total

1.  Panax notoginseng Saponins Protect Brain Microvascular Endothelial Cells against Oxygen-Glucose Deprivation/Resupply-Induced Necroptosis via Suppression of RIP1-RIP3-MLKL Signaling Pathway.

Authors:  Yanhong Hu; Hongtao Lei; Sai Zhang; Jiabao Ma; Soyeon Kang; Liangqin Wan; Fanghe Li; Fan Zhang; Tianshi Sun; Chujun Zhang; Weihong Li
Journal:  Neurochem Res       Date:  2022-07-29       Impact factor: 4.414

2.  Reductions in Hydrogen Sulfide and Changes in Mitochondrial Quality Control Proteins Are Evident in the Early Phases of the Corneally Kindled Mouse Model of Epilepsy.

Authors:  Christi Cho; Maxwell Zeigler; Stephanie Mizuno; Richard S Morrison; Rheem A Totah; Melissa Barker-Haliski
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

3.  Protection against Hypoxia-Reoxygenation Injury of Hippocampal Neurons by H2S via Promoting Phosphorylation of ROCK2 at Tyr722 in Rat Model.

Authors:  Meng Xue; Shuo Chen; Jiaojiao Xi; Qianjun Guan; Wei Chen; Yan Guo; Zhiwu Chen
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

4.  CSE/H2S ameliorates colitis in mice via protection of enteric glial cells and inhibition of the RhoA/ROCK pathway.

Authors:  Song Wang; Yanyu Ding; Wenjun Jiang
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.